Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dassault Systemes shares fall as revenue forecast disappoints

Published 01/02/2024, 06:09
Updated 01/02/2024, 08:40
© Reuters.

(Reuters) -Dassault Systemes said on Thursday it expects revenue growth of 8-10% this year at constant currencies, below analyst expectations and sending shares in the French software maker down around 9% in early trade.

The group, which sells software to automakers, planemakers and industrial firms, expects full-year non-IFRS revenue of 6.35 billion to 6.43 billion euros ($6.86 billion to $6.95 billion) in 2024 after it rose 9% last year.

Analysts in an LSEG poll forecast the company to report 2024 revenue of 6.48 billion euros.

The group's operating margin for the fourth quarter stood at 35.9% on revenue of 1.64 billion euros, just below expectations of 36.1% and 1.66 billion euros, respectively.

It sees an operating margin of 32.5% to 32.8% this year, compared with 32.4% in 2023.

Overall quarterly software revenue amounted to 1.48 billion euros, up 8% due to strong growth in subscriptions throughout the year. Subscription revenue brought in 1.12 billion euros in the fourth quarter.

Sales of its flagship software platform 3DEXPERIENCE, which offers 3D modelling, data management and project management tools, slowed to 21% in the fourth quarter from 46% in the previous quarter.

The group said it continued to invest in China, where sales returned to double-digit growth in the last quarter of 2023, as well as in the construction and infrastructure sectors.

"We are confident, even though we are cautious (...) We expect an improving situation versus 2023," finance chief Rouven Bergmann told journalists in an earnings call.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company's Medidata unit, which analyses patient data for clinical trials and where revenues have been falling since the COVID-19 pandemic, was still the weakest contributor to the group's total revenue in the fourth quarter, due to a high comparison base and continued slowdown in clinical study starts.

"We have experienced some softness in the life sciences industry ... But we also believe this will stabilize in 2024," Bergmann said.

In the first quarter of 2024 Dassault Systemes expects its revenue to grow between 7% and 8% in constant currencies, with an operating margin of 30.6% to 30.7%.

($1 = 0.9258 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.